Physician

Adam Rozenstrauch, D.P.M

According to 2025 Medicare claims, Adam Rozenstrauch, D.P.M (NPI: 1689055519) practices podiatry in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is PODIATRY FOOT & ANKLE INSTITUTE (NPI: 1407911035; TIN: 223079505) and primary practice location at 07601-1999. Rozenstrauch is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Rozenstrauch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 402 traditional Medicare patients, billed 1,312 HCPCS/CPT codes, and received $92,436 in Medicare payments. The top billing code was 99349 (Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes). Part D data shows 138 prescription claims across 81 beneficiaries totaling $3,791 in drug costs, led by Clotrimazole (Clotrimazole). Open Payments data shows 5 records totaling $122. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $3,696 and ending at $92,436. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $13,691 to $3,791. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	57	66	$3,696
2021	215	519	$38,128
2022	344	1,428	$105,950
2023	309	1,091	$73,402
2024	402	1,312	$92,436

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	141	239	$13,691
2019	261	641	$30,240
2020	74	143	$5,897
2021	63	90	$2,148
2022	76	136	$3,528
2023	63	90	$2,356
2024	81	138	$3,791

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99349	Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes	85	133	$110
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	88	188	$76
99348	Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes	72	94	$65
99308	Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more	70	106	$63
11720	Removal of fingernails or toenails, 1-5 nails	99	186	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Clotrimazole	Clotrimazole	40	1,235	$948
Ketoconazole	Ketoconazole	17	455	$433
Ammonium Lactate	Ammonium Lactate	17	625	$228
Cefdinir	Cefdinir	11	73	$173

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$122	TREACE MEDICAL CONCEPTS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Rozenstrauch, D.P.M?

Tedicare shows public-source Medicare data for Adam Rozenstrauch, D.P.M (NPI 1689055519), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Rozenstrauch, D.P.M have ACO affiliation data?

Adam Rozenstrauch, D.P.M is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Adam Rozenstrauch, D.P.M?

Adam Rozenstrauch, D.P.M is linked to PODIATRY FOOT & ANKLE INSTITUTE (billing NPI 1407911035) in the available physician profile data.

Does Adam Rozenstrauch, D.P.M have Open Payments data?

Adam Rozenstrauch, D.P.M has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.